Latest news and articles about CCTV 3.15
Total: 1 articles found
CCTV’s consumer‑rights programme named Zhengzhou Yuanchuang Gene in a probe of overhyped exosome products, and public records show several of the company’s patent applications have been rejected. The development highlights the tension between genuine exosome research and a market of unproven claims, and signals heightened regulatory and reputational risks for small biotech firms in China.
